Applications from the field of Pharma & Biopharma focused on ICP-OES - page 1

Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent ICP Expert 21 CFR Part 11 software

Technical notes

| 2020 | Agilent Technologies

Software, ICP-OES

Instrumentation

Software, ICP-OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

ICP Expert Software Installation Instructions for 21 CFR Part 11 Environments

Manuals

| 2018 | Agilent Technologies

Software, ICP-OES

Instrumentation

Software, ICP-OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Solutions for Vaccine Testing

Brochures and specifications

| 2020 | Shimadzu

Software, MALDI, HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/QQQ, ICP/MS, ICP-OES

Instrumentation

Software, MALDI, HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/QQQ, ICP/MS, ICP-OES

Manufacturer

Shimadzu

Industries

Pharma & Biopharma, Clinical Research

Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis

Technical notes

| 2014 | Agilent Technologies

ICP/MS, ICP-OES

Instrumentation

ICP/MS, ICP-OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-OES Solution

Technical notes

| 2021 | Agilent Technologies

Software, ICP-OES

Instrumentation

Software, ICP-OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma